Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Progesterone receptor membrane component 1 promotes survival of human breast cancer cells and the growth of xenograft tumors.

Clark NC, Friel AM, Pru CA, Zhang L, Shioda T, Rueda BR, Peluso JJ, Pru JK.

Cancer Biol Ther. 2016;17(3):262-71. doi: 10.1080/15384047.2016.1139240. Epub 2016 Jan 19.

2.

Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors.

Friel AM, Zhang L, Pru CA, Clark NC, McCallum ML, Blok LJ, Shioda T, Peluso JJ, Rueda BR, Pru JK.

Cancer Lett. 2015 Jan 28;356(2 Pt B):434-42. doi: 10.1016/j.canlet.2014.09.036. Epub 2014 Oct 7.

3.

Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells.

O'Brien K, Rani S, Corcoran C, Wallace R, Hughes L, Friel AM, McDonnell S, Crown J, Radomski MW, O'Driscoll L.

Eur J Cancer. 2013 May;49(8):1845-59. doi: 10.1016/j.ejca.2013.01.017. Epub 2013 Feb 27.

PMID:
23453937
4.

Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model.

McCann CK, Growdon WB, Kulkarni-Datar K, Curley MD, Friel AM, Proctor JL, Sheikh H, Deyneko I, Ferguson JA, Vathipadiekal V, Birrer MJ, Borger DR, Mohapatra G, Zukerberg LR, Foster R, Macdougall JR, Rueda BR.

PLoS One. 2011;6(11):e28077. doi: 10.1371/journal.pone.0028077. Epub 2011 Nov 29.

5.

Analysis of gene expression as relevant to cancer cells and circulating tumour cells.

Friel AM, Crown J, O'Driscoll L.

Methods Mol Biol. 2011;784:55-75. doi: 10.1007/978-1-61779-289-2_5.

PMID:
21898213
6.

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells.

Friel AM, Zhang L, Curley MD, Therrien VA, Sergent PA, Belden SE, Borger DR, Mohapatra G, Zukerberg LR, Foster R, Rueda BR.

Reprod Biol Endocrinol. 2010 Dec 1;8:147. doi: 10.1186/1477-7827-8-147.

7.

Intracellular and extracellular microRNAs in breast cancer.

Corcoran C, Friel AM, Duffy MJ, Crown J, O'Driscoll L.

Clin Chem. 2011 Jan;57(1):18-32. doi: 10.1373/clinchem.2010.150730. Epub 2010 Nov 8. Review.

8.

Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer.

Friel AM, Corcoran C, Crown J, O'Driscoll L.

Breast Cancer Res Treat. 2010 Oct;123(3):613-25. doi: 10.1007/s10549-010-0980-2. Epub 2010 Jun 15. Review.

PMID:
20549336
9.

Mouse models of uterine corpus tumors: clinical significance and utility.

Friel AM, Growdon WB, McCann CK, Olawaiye AB, Munro EG, Schorge JO, Castrillon DH, Broaddus RR, Rueda BR.

Front Biosci (Elite Ed). 2010 Jun 1;2:882-905. Review.

PMID:
20515761
10.

Evidence for cancer stem cells in human endometrial carcinoma.

Hubbard SA, Friel AM, Kumar B, Zhang L, Rueda BR, Gargett CE.

Cancer Res. 2009 Nov 1;69(21):8241-8. doi: 10.1158/0008-5472.CAN-08-4808. Epub 2009 Oct 20.

11.

CD133 expression defines a tumor initiating cell population in primary human ovarian cancer.

Curley MD, Therrien VA, Cummings CL, Sergent PA, Koulouris CR, Friel AM, Roberts DJ, Seiden MV, Scadden DT, Rueda BR, Foster R.

Stem Cells. 2009 Dec;27(12):2875-83. doi: 10.1002/stem.236.

12.

Beta-adrenoceptor subtype expression in human placenta and umbilical arteries in normal and preeclamptic pregnancies.

Hynes PG, Friel AM, Smith TJ, Morrison JJ.

Hypertens Pregnancy. 2008;27(2):169-81. doi: 10.1080/10641950701826554.

PMID:
18484422
13.

Functional analyses of the cancer stem cell-like properties of human endometrial tumor initiating cells.

Friel AM, Sergent PA, Patnaude C, Szotek PP, Oliva E, Scadden DT, Seiden MV, Foster R, Rueda BR.

Cell Cycle. 2008 Jan 15;7(2):242-9. Epub 2007 Oct 24.

PMID:
18256549
14.

Expression levels of mRNA for Rho A/Rho kinase and its role in isoprostane-induced vasoconstriction of human placental and maternal vessels.

Friel AM, Hynes PG, Sexton DJ, Smith TJ, Morrison JJ.

Reprod Sci. 2008 Feb;15(2):179-88. Epub 2007 Dec 18.

PMID:
18089586
15.

Mechanisms of Cables 1 gene inactivation in human ovarian cancer development.

Sakamoto H, Friel AM, Wood AW, Guo L, Ilic A, Seiden MV, Chung DC, Lynch MP, Serikawa T, Munro E, Oliva E, Orsulic S, Kirley SD, Foster R, Zukerberg LR, Rueda BR.

Cancer Biol Ther. 2008 Feb;7(2):180-88. Epub 2007 Nov 15.

PMID:
18059193
16.

Loss of CABLES1, a cyclin-dependent kinase-interacting protein that inhibits cell cycle progression, results in germline expansion at the expense of oocyte quality in adult female mice.

Lee HJ, Sakamoto H, Luo H, Skaznik-Wikiel ME, Friel AM, Niikura T, Tilly JC, Niikura Y, Klein R, Styer AK, Zukerberg LR, Tilly JL, Rueda BR.

Cell Cycle. 2007 Nov 1;6(21):2678-84. Epub 2007 Jul 31.

PMID:
17912041
17.

Expression and function of protease-activated receptor 4 in human myometrium.

Allen NM, O'Brien M, Friel AM, Smith TJ, Morrison JJ.

Am J Obstet Gynecol. 2007 Feb;196(2):169.e1-6.

PMID:
17306668
18.
19.

Specific PGF(2alpha) receptor (FP) antagonism and human uterine contractility in vitro.

Friel AM, O'Reilly MW, Sexton DJ, Morrison JJ.

BJOG. 2005 Aug;112(8):1034-42.

20.

Effects of thrombin, PAR-1 activating peptide and a PAR-1 antagonist on umbilical artery resistance in vitro.

O'Loughlin AJ, O'Sullivan CJ, Ravikumar N, Friel AM, Elliott JT, Morrison JJ.

Reprod Biol Endocrinol. 2005 Feb 24;3:8.

21.

Rho A/Rho kinase mRNA and protein levels in human myometrium during pregnancy and labor.

Friel AM, Curley M, Ravikumar N, Smith TJ, Morrison JJ.

J Soc Gynecol Investig. 2005 Jan;12(1):20-7.

PMID:
15629666
22.

Functional effects of 17alpha-hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro.

Sexton DJ, O'Reilly MW, Friel AM, Morrison JJ.

Reprod Biol Endocrinol. 2004 Dec 7;2:80.

23.

Thrombin and PAR1-activating peptide: effects on human uterine contractility in vitro.

O'Sullivan CJ, Allen NM, O'Loughlin AJ, Friel AM, Morrison JJ.

Am J Obstet Gynecol. 2004 Apr;190(4):1098-105.

PMID:
15118649
24.

Cannabinoids and the human uterus during pregnancy.

Dennedy MC, Friel AM, Houlihan DD, Broderick VM, Smith T, Morrison JJ.

Am J Obstet Gynecol. 2004 Jan;190(1):2-9; discussion 3A.

PMID:
14749627
25.

Expression of mRNA transcripts for ATP-sensitive potassium channels in human myometrium.

Curley M, Cairns MT, Friel AM, McMeel OM, Morrison JJ, Smith TJ.

Mol Hum Reprod. 2002 Oct;8(10):941-5.

PMID:
12356945
26.

Expression and modulation of Rho kinase in human pregnant myometrium.

Moran CJ, Friel AM, Smith TJ, Cairns M, Morrison JJ.

Mol Hum Reprod. 2002 Feb;8(2):196-200.

PMID:
11818523
27.

Uterine relaxant effects of cyclooxygenase-2 inhibitors in vitro.

Slattery MM, Friel AM, Healy DG, Morrison JJ.

Obstet Gynecol. 2001 Oct;98(4):563-9.

PMID:
11576568
28.

Beta-3 versus beta-2 adrenergic agonists and preterm labour: in vitro uterine relaxation effects.

Dennedy MC, Friel AM, Gardeil F, Morrison JJ.

BJOG. 2001 Jun;108(6):605-9.

Supplemental Content

Loading ...
Support Center